Trial intelligence / Profile preview

Zestra for Mixed Female Sexual Dysfunction

NCT00118495Phase 3Completed

Sponsor
Qualilife Pharmaceuticals
Start
Mar 2006
Modality
PE (Plant Extract)
Countries
1
01

Overview

A Phase 3 trial of Zestra in female sexual dysfunction (FSD), sponsored by Qualilife Pharmaceuticals. Started Mar 2006; status: completed.

02

Drugs

Zestra
03

Conditions

female sexual dysfunction (FSD)

Beyond the preview

Go deeper on NCT00118495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00118495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call